EUVIMEDEUVIMED entdecken
Crossref

Abstract 1528: Balancing Thrombosis and Bleeding After Carotid Artery Stenting: A Multicenter Comparative Analysis of Antithrombotic Strategies

M. El-Ghanem, Y. J Alderazi, A. Alshekhlee, C. Ezepue, L. Mealer, O. Zaidat, M. Hussain, M. Niazi, F. Sheriff, A. Hassan, S. Bushnaq, K. Asif und 12 weitere

Stroke: Vascular and Interventional Neurology · 18.10.2026 · 6 (Suppl_1)

DOI: 10.1161/svi270000_1528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke: Vascular and Interventional Neurology, erschienen am 18.10.2026. Verfasst von M. El-Ghanem und 23 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Purpose: Optimal antithrombotic therapy after carotid artery stenting (CAS), particularly in patients requiring oral anticoagulation (OAC),remains uncertain. We compared postprocedural antithrombotic strategies with respect to ischemic, thrombotic, and bleedingoutcomes after CAS. Materials/Methods: We analyzed 2,114 patients undergoing CAS from the combined CASSH and CASONI cohorts. Postprocedural therapy consistedof dual antiplatelet therapy (DAPT; n=1,952), OAC plus a single antiplatelet agent (n=91), triple therapy (n=34), or singleantiplatelet therapy (n=37). Within DAPT, 1,704 patients received aspirin plus clopidogrel and 248 received aspirin plusticagrelor. The primary composite included 30-day procedure-related mortality, symptomatic ischemic or hemorrhagic stroke, andmyocardial infarction. The secondary composite included nonprocedure-related mortality, asymptomatic intracranial hemorrhage,transient ischemic attack/minor ischemic stroke, distal embolization, access-site complications, stent thrombosis, and otherprocedural complications. Bleeding events comprised intracranial hemorrhage, gastrointestinal bleeding, and access-sitebleeding, including retroperitoneal hemorrhage. Propensity-score overlap weighting was used for treatment comparisons, withFirth penalized logistic regression as a complementary analysis for sparse events.

Results

Among DAPT-treated patients, aspirin plus ticagrelor was associated with higher secondary-composite risk (OW RR 2.55, 95%CI 1.34-4.85; P=.004) and bleeding risk (OW RR 4.05, 95% CI 1.13-14.43; P=.031) versus aspirin plus clopidogrel, without asignificant difference in the primary composite. OAC plus a single antiplatelet agent did not differ significantly from DAPT inthe secondary composite (OW RR 0.76, 95% CI 0.22-2.65; P=.661); primary and bleeding comparisons were not estimablebecause no events occurred in the OAC group. Triple therapy versus DAPT showed higher point estimates for the primarycomposite (OW RR 4.33, 95% CI 0.88-21.34; P=.072), secondary composite (OW RR 2.92, 95% CI 0.84-10.17; P=.092), andbleeding (OW RR 2.46, 95% CI 0.34-17.84; P=.372), but these estimates were highly imprecise because of the small number ofpatients and sparse events. Triple therapy versus OAC plus a single antiplatelet agent was similarly imprecise, with a secondary-composite OW RR of 4.21 (95% CI 0.59-30.18; P=.153), while primary and bleeding RRs were not estimable because of zeroevents in the OAC group. Firth regression yielded broadly concordant findings.

Conclusion

After CAS, aspirin plus ticagrelor was associated with higher secondary-event and bleeding risk compared with aspirin plusclopidogrel. OAC plus a single antiplatelet agent showed no clear excess risk compared with DAPT, whereas estimates for tripletherapy were limited by small sample size and sparse events. These findings support careful selection of post-CAS antithrombotictherapy and highlight the need to balance thrombotic protection against bleeding risk.

Zitieren

APA

El-Ghanem, M., Alderazi, Y. J., Alshekhlee, A., Ezepue, C., Mealer, L., Zaidat, O., Hussain, M., Niazi, M., Sheriff, F., Hassan, A., Bushnaq, S., Asif, K., Tanweer, O., Alaraj, A., Grandhi, R., Janjua, N., Vela-Duarte, D., Siddiq, F., Chaubal, V., …, & Ezzeldin, M. (2026). Abstract 1528: Balancing Thrombosis and Bleeding After Carotid Artery Stenting: A Multicenter Comparative Analysis of Antithrombotic Strategies. Stroke: Vascular and Interventional Neurology, 6(Suppl_1). https://doi.org/10.1161/svi270000_1528

Vancouver

El-Ghanem M, Alderazi YJ, Alshekhlee A, Ezepue C, Mealer L, Zaidat O, et al. Abstract 1528: Balancing Thrombosis and Bleeding After Carotid Artery Stenting: A Multicenter Comparative Analysis of Antithrombotic Strategies. Stroke: Vascular and Interventional Neurology. 2026;6(Suppl_1). doi:10.1161/svi270000_1528

BibTeX
@article{ElGhanem2026,
  author = {El-Ghanem, M. and Alderazi, Y. J and Alshekhlee, A. and Ezepue, C. and Mealer, L. and Zaidat, O. and Hussain, M. and Niazi, M. and Sheriff, F. and Hassan, A. and Bushnaq, S. and Asif, K. and Tanweer, O. and Alaraj, A. and Grandhi, R. and Janjua, N. and Vela-Duarte, D. and Siddiq, F. and Chaubal, V. and Khaled, A. and Hamed, E. and Ghanem, L. El and Ali, Z. and Ezzeldin, M.},
  title = {Abstract 1528: Balancing Thrombosis and Bleeding After Carotid Artery Stenting: A Multicenter Comparative Analysis of Antithrombotic Strategies},
  journal = {Stroke: Vascular and Interventional Neurology},
  year = {2026},
  volume = {6},
  number = {Suppl_1},
  doi = {10.1161/svi270000_1528}
}
Kostenlos starten →